相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。QT effects of bedaquiline, delamanid, or both in patients with rifampicin-resistant tuberculosis: a phase 2, open-label, randomised, controlled trial
Kelly E. Dooley et al.
LANCET INFECTIOUS DISEASES (2021)
Effectiveness and safety of delamanid- or bedaquiline-containing regimens among children and adolescents with multidrug resistant or extensively drug resistant tuberculosis: A nationwide study from Belarus, 2015-19
Varvara Solodovnikova et al.
MONALDI ARCHIVES FOR CHEST DISEASE (2021)
New TB drugs for the treatment of children and adolescents with rifampicin-resistant TB in Mumbai, India
M. Das et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2020)
Improved Treatment Outcomes With Bedaquiline When Substituted for Second-line Injectable Agents in Multidrug-resistant Tuberculosis: A Retrospective Cohort Study
Ying Zhao et al.
CLINICAL INFECTIOUS DISEASES (2019)
Adverse drug reactions in South African patients receiving bedaquiline-containing tuberculosis treatment: an evaluation of spontaneously reported cases
Jackie Jones et al.
BMC INFECTIOUS DISEASES (2019)
Successful implementation of bedaquiline for multidrug-resistant TB treatment in remote Papua New Guinea
M. Taune et al.
PUBLIC HEALTH ACTION (2019)
Bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis: a multicentre cohort study in Korea
Cheon Tae Kim et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Long-term bedaquiline-related treatment outcomes in patients with extensively drug-resistant tuberculosis from South Africa
Olatunde Olayanju et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Effect of bedaquiline on mortality in South African patients with drug-resistant tuberculosis: a retrospective cohort study
Kathryn Schnippel et al.
LANCET RESPIRATORY MEDICINE (2018)
Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study
Sergey E. Borisov et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis
Alexander S. Pym et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Bactericidal mode of action of bedaquiline
Kiel Hards et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Compassionate Use of Bedaquiline for the Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Interim Analysis of a French Cohort
Lorenzo Guglielmetti et al.
CLINICAL INFECTIOUS DISEASES (2015)
Additional Drug Resistance of Multidrug-Resistant Tuberculosis in Patients in 9 Countries
Ekaterina V. Kurbatova et al.
EMERGING INFECTIOUS DISEASES (2015)
Multidrug-Resistant Tuberculosis and Culture Conversion with Bedaquiline
Andreas H. Diacon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
TMC207: the first compound of a new class of potent anti-tuberculosis drugs
Alberto Matteelli et al.
FUTURE MICROBIOLOGY (2010)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
ANNALS OF INTERNAL MEDICINE (2009)
Diarylquinolines target subunit c of mycobacterial ATP synthase
Anil Koul et al.
NATURE CHEMICAL BIOLOGY (2007)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
分享论文
